Edge Wealth Management’s Fortress Biotech FBIO Stock Holding History

Edge Wealth Management’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-400	Closed	-$21K	–	448
2021 Q1	$21K	Hold	400	–	–	﹤0.01%	265
2020 Q4	$19K	Hold	400	–	–	﹤0.01%	244
2020 Q3	$24K	Hold	400	–	–	0.01%	252
2020 Q2	$16K	Hold	400	–	–	﹤0.01%	395
2020 Q1	$11K	Hold	400	–	–	﹤0.01%	385
2019 Q4	$15K	Hold	400	–	–	﹤0.01%	372
2019 Q3	$8K	Hold	400	–	–	﹤0.01%	435
2019 Q2	$9K	Buy	+400	New	+$10.3K	﹤0.01%	426
2015 Q2	–	Sell	-100	Closed	-$6K	–	436
2015 Q1	$6K	Hold	100	–	–	﹤0.01%	331
2014 Q4	$3K	Hold	100	–	–	﹤0.01%	366
2014 Q3	$3K	Hold	100	–	–	﹤0.01%	364
2014 Q2	$3K	Sell	100 -400	-80%	-$10.5K	﹤0.01%	339
2014 Q1	$15K	Sell	500 -2,000	-80%	-$78K	0.01%	258
2013 Q4	$99K	Buy	2,500 +2,400	+2,400%	+$92.7K	0.05%	124
2013 Q3	$11K	Sell	100 -107	-52%	-$13.1K	0.01%	235
2013 Q2	$27K	Buy	+207	New	+$30.5K	0.02%	164

Other funds holding FBIO

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

SAM

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Edge Wealth Management's FBIO Position: Q2 2021 in Review

Edge Wealth Management sold out of Fortress Biotech (FBIO) in Q2 2021, closing a stake of 400 shares — an estimated $21K sold.

Edge Wealth Management first reported a position in FBIO in Q2 2013 and held it in 16 quarters. The position peaked at $99K in Q4 2013. 84 funds tracked by Wall St. Rank hold FBIO as of Q2 2021.

Edge Wealth Management reported no remaining Fortress Biotech position as of Q2 2021 after selling out during the quarter.
Edge Wealth Management sold 400 Fortress Biotech shares in Q2 2021, an estimated $21K.
Edge Wealth Management first reported a position in Fortress Biotech in Q2 2013 and held it in 16 quarters.
Edge Wealth Management's Fortress Biotech position peaked at $99K in Q4 2013.
84 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2021.

Based on Edge Wealth Management's 13F filing for Q2 2021, filed 23 Jul 2021.